Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Motor Activity × secukinumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 1 Lymphoma, Follicular 1 Crohn Disease 1

Interventions

Exercise 9 Standard of Care 2 Resistance Training 2 High-Intensity Interval Training 2 secukinumab 1 methyl hydroxyethyl cellulose 1 Walking 1 Metformin 1 Focus Groups 1 Exercise Therapy 1 Diet Therapy 1 Control Groups 1 Cognitive Training 1 Caloric Restriction 1 Andrographis paniculata extract 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00584740 2015-03-31

Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease

Novartis

Phase 2 Terminated

59 enrolled 13 charts

Crohn Disease, Lymphoma, Follicular, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡